This company has been acquired
Prometheus Biosciences Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Prometheus Biosciences does not have a record of paying a dividend.
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Ausschüttungsquote
Durchschnittlicher Branchenertrag | 1.9% |
Nächster Dividendenzahlungstermin | n/a |
Ex-Dividendendatum | n/a |
Dividende pro Aktie | n/a |
Gewinn pro Aktie | -US$3.15 |
Prognose der Dividendenrendite | 0% |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.26M beats by $0.8M
Aug 11We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus: Biotech To Watch With A Monoclonal Antibody For Immune-Mediated Diseases
Dec 08Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Prometheus Biosciences: Precision Medicine For IBD
Sep 22Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if RXDX's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if RXDX's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
Prometheus Biosciences Dividendenrendite im Vergleich zum Markt |
---|
Segment | Dividendenrendite |
---|---|
Unternehmen (RXDX) | n/a |
Untere 25 % des Marktes (US) | 1.4% |
Markt Top 25 % (US) | 4.4% |
Branchendurchschnitt (Biotechs) | 1.9% |
Analystenprognose (RXDX) (bis zu 3 Jahre) | 0% |
Bemerkenswerte Dividende: Unable to evaluate RXDX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate RXDX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as RXDX has not reported any payouts.